Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,986,732
+$6,902,295 QoQ
Shares Held
2,200,695
+21.7% QoQ
Ownership
0.675%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 208 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. TSHA ranks #87 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in TSHA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,986,732 2,200,695
2026-03-31 $8,084,437 1,808,599
2025-12-31 $10,466,379 1,902,978
2025-09-30 $6,038,087 1,846,510
2025-06-30 $1,135,847 491,709
2025-03-31 $760,507 547,128
2024-12-31 $820,464 474,257
2024-09-30 $930,362 462,867
2024-06-30 $962,626 429,744
2024-03-31 $147,695 51,462
2023-12-31 $28,567 16,140
2023-09-30 $51,002 16,140
2023-06-30 $10,668 16,140
2023-03-31 $12,879 16,140
2022-12-31 $36,476 16,140
2022-09-30 $31,150 16,140
2022-06-30 $337,444 90,711
2022-03-31 $1,078,049 165,345
2021-12-31 $1,893,824 162,560
2021-09-30 $2,949,538 158,407
2021-06-30 $1,845,036 87,030
2021-03-31 $1,182,332 58,243
2020-12-31 $1,386,237 52,232